Xbiotech Inc (NQ: XBIT )
16.95 USD +0.58 (+3.54%) Official Closing Price Updated: 6:52 PM EST, Jan 21, 2021 Add to My Watchlist
All news about Xbiotech Inc
XBiotech Candidate True Human™ COVID-19 Therapy Found to Target Highly Infectious Emerging Strain
January 21, 2021
With New Infectious Strain Rapidly Spreading, XBiotech Establishes Data Indicating its Candidate True Human™ COVID-19 Therapy may be Effective for Treating New Mutant Strain
XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy
January 19, 2021
Appointments Include: Chair, Clay Johnston, M.D., Ph.D. as well as Members Greg Albers, M.D. and Brett Cucchiara, M.D.
XBiotech is Now Oversold (XBIT)
December 29, 2020
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
66 Biggest Movers From Friday
November 23, 2020
Gainers Kaixin Auto Holdings (NASDAQ: KXIN) shares jumped 103.3% to close at $6.06 on Friday. FTS International Inc (NYSE: FTSI) ...
XBiotech Data Shows Effective Anti-Virus Activity for True Human Antibodies in Its Candidate Influenza-COVID-19 Therapeutic Cocktail
November 19, 2020
XBiotech Developing True Human Antibody Combination as Candidate Treatment for Influenza-COVID-19 Co-Infections
September 21, 2020
With the Arrival of Flu Season, Development of a Breakthrough Therapeutic for Treating Influenza and COVID-19 Co-Infections is Urgently Needed
80 Biggest Movers From Yesterday
August 25, 2020
Gainers Cancer Genetics, Inc. (NASDAQ: CGIX) shares climbed 114.8% to close at $6.25 on Monday after the company signed a ...
60 Stocks Moving In Monday's Mid-Day Session
August 24, 2020
Gainers Cancer Genetics, Inc. (NASDAQ: CGIX) shares jumped 178.7% to $8.11 after the company signed a definitive merger agreement ...
XBiotech-Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use Authorization
August 24, 2020
XBiotech Discovers COVID-19 Candidate Therapy
August 17, 2020
The Company has Identified Highly Targeted Anti-COVID-19 True Human Antibodies from Immune Donor Blood
5 Value Stocks In The Healthcare Sector
August 03, 2020
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that ...
XBIT Crosses Below Key Moving Average Level
July 29, 2020
In trading on Wednesday, shares of XBiotech Inc (XBIT) crossed below their 200 day moving average of $14.68, changing hands as low as $14.60 per share. XBiotech Inc shares are currently trading off...
XBiotech Achieves Milestone for Production of its New Potential Blockbuster Anti-IL-1⍺ Therapy
July 22, 2020
After Sale of its Previous Anti-IL-1a True Human Antibody, Company Now Has Production Cell to Manufacture New Molecule for Launch of Clinical Studies in 2021
XBiotech Announces Discovery that Blocking Interleukin-1a Reduces Brain Injury and Neurological Deficit After Stroke
July 14, 2020
Antibody Therapy Targeting Interleukin-1a significantly reduced stroke related brain injury in animals and points to new potential blockbuster therapy
XBiotech Identifies “Super Bloods” for the Development of a True Human™ COVID-19 Therapy
May 01, 2020
SmarTrend identified an Uptrend for Xbiotech Inc (NASDAQ:XBIT) on April 6th, 2020 at $12.29. In approximately 3 weeks, Xbiotech Inc has returned 10.54% as of today's recent price of...
New antibody to block IL-1⍺ scheduled to enter clinical trials as next generation anti-inflammatory therapy in 2021
First Week of May 15th Options Trading For XBiotech (XBIT)
April 07, 2020
Investors in XBiotech Inc (XBIT) saw new options become available this week, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XBIT options chain...
Bullish Two Hundred Day Moving Average Cross - XBIT
April 06, 2020
In trading on Monday, shares of XBiotech Inc (XBIT) crossed above their 200 day moving average of $12.20, changing hands as high as $13.50 per share. XBiotech Inc shares are currently trading up about...
26 Stocks Moving in Monday's Pre-Market Session
April 06, 2020
Gainers Mesoblast Limited (NASDAQ: MESO) shares rose 54.8% to $6.50 in pre-market trading after the company received the FDA ...
Pre-open movers U.S. stock futures traded higher in early pre-market trade. The U.S. is now the epicenter of the coronavirus ...
5 Stocks To Watch For April 6, 2020
April 06, 2020
Some of the stocks that may grab investor focus today are: Wall Street expects Simply Good Foods Co (NASDAQ: SMPL) to report ...
XBiotech and BioBridge Global Collaborate on FDA Program to Develop Potential COVID-19 Treatment Based on Natural Antibodies from Recovered Patients
April 03, 2020
SmarTrend identified a Downtrend for Xbiotech Inc (NASDAQ:XBIT) on February 13th, 2020 at $17.10. In approximately 2 months, Xbiotech Inc has returned 35.15% as of today's recent price of...
SmarTrend identified a Downtrend for Xbiotech Inc (NASDAQ:XBIT) on February 13th, 2020 at $17.10. In approximately 1 month, Xbiotech Inc has returned 44.62% as of today's recent price of...
SmarTrend identified a Downtrend for Xbiotech Inc (NASDAQ:XBIT) on February 13th, 2020 at $17.10. In approximately 3 weeks, Xbiotech Inc has returned 35.20% as of today's recent price of...
XBIT Makes Notable Cross Below Critical Moving Average
March 02, 2020
In trading on Monday, shares of XBiotech Inc (XBIT) crossed below their 200 day moving average of $11.89, changing hands as low as $11.80 per share. XBiotech Inc shares are currently trading off about...
76 Biggest Movers From Friday
February 18, 2020
Gainers Summer Infant, Inc. (NASDAQ: SUMR) shares climbed 288% to close at $1.05 on Friday after the company reported ...
Analysts See 18% Gains Ahead For The Holdings of BIB
February 14, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
From ETF Channel